BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28639030)

  • 21. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan.
    Jagsi R; Griffith KA; Heimburger D; Walker EM; Grills IS; Boike T; Feng M; Moran JM; Hayman J; Pierce LJ;
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1010-6. PubMed ID: 25539366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
    Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
    Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypofractionated Nodal Radiation Therapy for Breast Cancer Was Not Associated With Increased Patient-Reported Arm or Brachial Plexopathy Symptoms.
    Leong N; Truong PT; Tankel K; Kwan W; Weir L; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1166-1172. PubMed ID: 29165285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.
    Laucis AM; Jagsi R; Griffith KA; Dominello MM; Walker EM; Abu-Isa EI; Dilworth JT; Vicini F; Kocheril PG; Browne CH; Mietzel MA; Moran JM; Hayman JA; Pierce LJ;
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):949-958. PubMed ID: 32376311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of hypofractionated post-mastectomy radiotherapy reduces health costs by over $2000 per patient: An Australian perspective.
    Mortimer JW; McLachlan CS; Hansen CJ; Assareh H; Last A; McKay MJ; Shakespeare TP
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):146-53. PubMed ID: 26511607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofractionated radiation treatment in the management of breast cancer.
    Gupta A; Ohri N; Haffty BG
    Expert Rev Anticancer Ther; 2018 Aug; 18(8):793-803. PubMed ID: 29902386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
    Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy : Results of a single, institutional, retrospective study.
    Rudat V; Nour A; Hammoud M; Abou Ghaida S
    Strahlenther Onkol; 2017 May; 193(5):375-384. PubMed ID: 28233048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes.
    Chan EK; Woods R; McBride ML; Virani S; Nichol A; Speers C; Wai ES; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):786-92. PubMed ID: 24606848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
    Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
    JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
    Smith BD; Bentzen SM; Correa CR; Hahn CA; Hardenbergh PH; Ibbott GS; McCormick B; McQueen JR; Pierce LJ; Powell SN; Recht A; Taghian AG; Vicini FA; White JR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):59-68. PubMed ID: 20638191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypofractionated whole-breast radiotherapy and concomitant boost after breast conservation in elderly patients.
    Cante D; Franco P; Sciacero P; Girelli G; Pasquino M; Casanova Borca V; Tofani S; Porta MR; Ricardi U
    Tumori; 2016; 102(2):196-202. PubMed ID: 26350199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New innovative techniques in radiotherapy for breast cancer.
    Murphy JO; Sacchini VS
    Minerva Chir; 2013 Apr; 68(2):139-54. PubMed ID: 23612227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation.
    Rovea P; Fozza A; Franco P; De Colle C; Cannizzaro A; Di Dio A; De Monte F; Rosmino C; Filippi AR; Ragona R; Ricardi U
    Clin Breast Cancer; 2015 Aug; 15(4):270-6. PubMed ID: 25666079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypofractionation with no boost after breast conservation in early-stage breast cancer patients.
    Arcadipane F; Franco P; De Colle C; Rondi N; Di Muzio J; Pelle E; Martini S; Ala A; Airoldi M; Donadio M; De Sanctis C; Castellano I; Ragona R; Ricardi U
    Med Oncol; 2016 Oct; 33(10):108. PubMed ID: 27573380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
    De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
    Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.
    Barbieri V; Sanpaolo P; Genovesi D
    Clin Breast Cancer; 2011 Apr; 11(2):114-20. PubMed ID: 21569997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.